十二指肠细菌载量:无症状对照、功能性胃肠病与炎症性肠病的qPCR比较
该研究用qPCR测定237例受试者十二指肠黏膜细菌载量,发现功能性胃肠病患者载量高于无症状对照及溃疡性结肠炎和克罗恩病患者;质子泵抑制剂治疗与载量升高独立相关,载量升高与标准营养激发试验症状反应增强相关。
要点
- 功能性胃肠病患者十二指肠细菌载量高于无症状对照及炎症性肠病患者。
- 质子泵抑制剂治疗与十二指肠细菌载量升高独立相关。
- 细菌载量升高与标准营养激发试验症状反应增强相关。
核心结论
- 功能性胃肠病诊断和质子泵抑制剂治疗均与十二指肠细菌载量升高独立相关。
- 细菌载量升高与标准营养激发试验后症状反应增强相关。
研究设计与样本
- 纳入237例受试者,包括63例无症状对照、84例功能性胃肠病和90例炎症性肠病(含溃疡性结肠炎和克罗恩病)。
- 内镜下无菌采集十二指肠黏膜样本,提取DNA,以qPCR测定细菌16S rRNA基因并归一化于人β-肌动蛋白表达计算细菌载量。
- 进行标准葡萄糖呼气试验和营养激发试验。
主要发现
- 功能性胃肠病患者十二指肠细菌载量(0.22 ± 0.03)高于无症状对照(0.07 ± 0.05;P = 0.007)。
- 功能性胃肠病患者细菌载量高于溃疡性结肠炎(0.01 ± 0.05)或克罗恩病(0.02 ± 0.09)患者(P = 0.0001)。
- 接受质子泵抑制剂治疗的患者细菌载量显著高于未使用者(P < 0.05),但未解释患者组与对照间的差异。
- 细菌载量与标准营养激发试验的症状反应显著相关(r = 0.21,P < 0.016)。
- 葡萄糖呼气试验中甲烷值而非氢值与qPCR测定的细菌载量相关。
临床怎么用
- 对于功能性胃肠病患者,可考虑评估十二指肠细菌载量及质子泵抑制剂使用对症状的潜在影响。
- 标准营养激发试验症状反应增强可能与细菌载量升高相关,提示临床关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Small intestinal bacterial overgrowth may play a role in gastrointestinal and non-gastrointestinal diseases. AIMS: To use quantitative polymerase chain reaction (qPCR) to determine and compare bacterial loads of duodenal biopsies in asymptomatic controls, and patients with functional gastrointestinal disorders (FGIDs) and inflammatory bowel disease (IBD) including ulcerative colitis (UC) and Crohn's disease (CD). To define effects of gastric acid inhibition on bacterial load, explore links of bacterial load and gastrointestinal symptoms in response to a standardised nutrient challenge and compare bacterial load with glucose breath test results. METHODS: In 237 patients (63 controls, 84 FGID and 90 IBD), we collected mucosal samples under aseptic conditions during endoscopy extracted and total DNA. Bacterial load metric was calculated utilising qPCR measurements of the bacterial 16S rRNA gene, normalised to human beta-actin expression. Standard glucose breath test and nutrient challenge test were performed. RESULTS: The duodenal microbial load was higher in patients with FGID (0.22 ± 0.03) than controls (0.07 ± 0.05; P = 0.007) and patients with UC (0.01 ± 0.05) or CD (0.02 ± 0.09), (P = 0.0001). While patients treated with proton pump inhibitors (PPI) had significantly higher bacterial loads than non-users (P < 0.05), this did not explain differences between patient groups and controls. Bacterial load was significantly (r = 0.21, P < 0.016) associated with the symptom response to standardised nutrient challenge test. Methane, but not hydrogen values on glucose breath test were associated with bacterial load measured utilising qPCR. CONCLUSIONS: Utilising qPCR, a diagnosis of FGID and treatment with PPI were independently associated with increased bacterial loads. Increased bacterial loads are associated with an augmented symptom response to a standardised nutrient challenge.
引用
- Shah A, Talley NJ, Koloski N, et al. Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease. Aliment Pharmacol Ther. 2020. PMID: 32412673. doi:10.1111/apt.15786
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。